You have to wonder if U.S. Sen. Cory Gardner (R-CO) is going to produce new information about the latest GOP bill to kill Obamacare–something that might make it, at least, look more appealing to Colorado, which stands to lose billions of dollars in federal health care dollars and to see a spike in the number of people uninsured.

Asked about about the bill, called Graham-Cassidy, last month, on Aug. 2, by KDMT 1690-AM’s Jimmy Sengenberger, on his “Business for Breakfast” show, Gardner hinted that he might have some information that no one else has.

Gardner: “But I certainly am interested in it. And I think it’s the right direction… So, it is something that I am very intrigued by. I’d have to understand how the formula works a little bit. And they’re being very quiet about how the formula would work. But it does sound like it could result in a 42 percent increase in funding for the state of Colorado. And so, I just need to learn more about it.”

Gardner did not say a 41 percent increase, nor did he say a 43 percent increase. It was precisely 42 percent, making it appear as if someone whispered a specific numeral in his ear, and the numeral emerged later from his mouth on the radio.

But where or where did Gardner get this figure?

Adam Fox, a spokesman for the Colorado Consumer Health Initiative, speculated that the 42-percent figure might have come from U.S. Bill Cassidy (R-LA), the sponsor of the legislation. He was circulating numbers weeks ago showing that some states would benefit from his bill, but his work was discredited, and he’s not produced new numbers, Fox said.

“Multiple studies have slightly different numbers, but they show drastic cuts, especially in states like Colorado that expanded Medicaid. Cassidy-Graham penalizes states like Colorado that covered more people,” said Fox.

“All outside analyses show that Cassidy-Graham will hurt Colorado and devastate our state budget,” Fox said.

Listen to Gardner here:

This entry was posted
on Thursday, September 21st, 2017 at 12:58 pm and is filed under Colorado U.S. Senate.
You can follow any responses to this entry through the RSS 2.0 feed.
You can skip to the end and leave a response. Pinging is currently not allowed.